Literature DB >> 35355749

Investigation of Interferon Gamma Activity Using Bioinformatics Methods.

N E Hassan1, A A Al-Janabi1.   

Abstract

Breast cancer grows from the breast tissue and is a severe health problem worldwide. Genetics is believed to be the primary cause of all cases of breast cancer via gene mutation. Bioinformatics methodology has been used to determine the sequences and structures of bioactive substances. This study aimed to analyze the function and structure of the Interferon Gamma (IFNγ) in healthy controls and patients with breast cancer using bioinformatics methods. Blood samples were collected from 75 patients with breast cancer and 25 healthy subjects as control samples. The results showed transition mutation (30%) and transversion mutation (70%) in patients with breast cancer. Moreover, missense mutations (84%) and silent mutations (16%) were detected by BLAST. In addition, the amino acid of the IFNγ protein consisting of alpha-helical, β-sheet, and coil of secondary structure was determined in this study using BioEdit. The results of the physicochemical properties of the IFNγ protein reflect the function, stability, molecular weight, isoelectric point, and instability index of the IFNγ protein using ProtParam. Moreover, the results of mutation affected the percentage of alpha-helix, β-turns, and coil in breast cancer patients compared to healthy groups with reference of NCBI using PSIpred program. Additionally, the PHYRE2 server and RasMol program showed a tertiary structure of the IFNγ protein in breast cancer patients. Furthermore, the STRING program revealed the poly IFNγ protein interacted with other proteins to perform its functions normally. From the recorded data in the current study, it was concluded that IFNγ is considered a marker for patients with breast cancer.

Entities:  

Keywords:  Bioinformatics Technique; Breast Cancer; Interferon Gamma

Mesh:

Substances:

Year:  2021        PMID: 35355749      PMCID: PMC8934094          DOI: 10.22092/ari.2021.356106.1780

Source DB:  PubMed          Journal:  Arch Razi Inst        ISSN: 0365-3439


  38 in total

1.  Point mutations and sequence variability in proteins: redistributions of preexisting populations.

Authors:  N Sinha; R Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Applicability of Instability Index for In vitro Protein Stability Prediction.

Authors:  Dilani G Gamage; Ajith Gunaratne; Gopal R Periyannan; Timothy G Russell
Journal:  Protein Pept Lett       Date:  2019       Impact factor: 1.890

3.  Mutation rates in mammalian genomes.

Authors:  Sudhir Kumar; Sankar Subramanian
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

4.  Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemia.

Authors:  Guillermo Montalban-Bravo; Faezeh Darbaniyan; Rashmi Kanagal-Shamanna; Irene Ganan-Gomez; Caleb A Class; Koji Sasaki; Kiran Naqvi; Yue Wei; Hui Yang; Kelly A Soltysiak; Kelly S Chien; Carlos Bueso-Ramos; Kim-Anh Do; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Leuk Res       Date:  2021-01-19       Impact factor: 3.156

5.  A Population-Based Study of Genes Previously Implicated in Breast Cancer.

Authors:  Chunling Hu; Steven N Hart; Rohan Gnanaolivu; Hongyan Huang; Kun Y Lee; Jie Na; Chi Gao; Jenna Lilyquist; Siddhartha Yadav; Nicholas J Boddicker; Raed Samara; Josh Klebba; Christine B Ambrosone; Hoda Anton-Culver; Paul Auer; Elisa V Bandera; Leslie Bernstein; Kimberly A Bertrand; Elizabeth S Burnside; Brian D Carter; Heather Eliassen; Susan M Gapstur; Mia Gaudet; Christopher Haiman; James M Hodge; David J Hunter; Eric J Jacobs; Esther M John; Charles Kooperberg; Allison W Kurian; Loic Le Marchand; Sara Lindstroem; Tricia Lindstrom; Huiyan Ma; Susan Neuhausen; Polly A Newcomb; Katie M O'Brien; Janet E Olson; Irene M Ong; Tuya Pal; Julie R Palmer; Alpa V Patel; Sonya Reid; Lynn Rosenberg; Dale P Sandler; Christopher Scott; Rulla Tamimi; Jack A Taylor; Amy Trentham-Dietz; Celine M Vachon; Clarice Weinberg; Song Yao; Argyrios Ziogas; Jeffrey N Weitzel; David E Goldgar; Susan M Domchek; Katherine L Nathanson; Peter Kraft; Eric C Polley; Fergus J Couch
Journal:  N Engl J Med       Date:  2021-01-20       Impact factor: 91.245

6.  miR-383 reduces keratinocyte proliferation and induces the apoptosis in psoriasis via disruption of LCN2-dependent JAK/STAT pathway activation.

Authors:  Hong Wang; Yangchun Xu; Meishan Jin; Hongxia Li; Shanshan Li
Journal:  Int Immunopharmacol       Date:  2021-04-02       Impact factor: 4.932

7.  Interferon-gamma release assay levels and risk of progression to active tuberculosis: a systematic review and dose-response meta-regression analysis.

Authors:  Jorge R Ledesma; Jianing Ma; Peng Zheng; Jennifer M Ross; Theo Vos; Hmwe H Kyu
Journal:  BMC Infect Dis       Date:  2021-05-22       Impact factor: 3.090

8.  Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces.

Authors:  Hanka Venselaar; Tim A H Te Beek; Remko K P Kuipers; Maarten L Hekkelman; Gert Vriend
Journal:  BMC Bioinformatics       Date:  2010-11-08       Impact factor: 3.169

9.  Characterization of Disease-Associated Mutations in Human Transmembrane Proteins.

Authors:  János Molnár; Gergely Szakács; Gábor E Tusnády
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

10.  Hematopoietic Stem Cell Transplantation for Patients with Autosomal Recessive Complete INF-λ Receptor 2 Deficiency: Experience in Oman.

Authors:  Hanan F Nazir; Abdulhakim Al Rawas; Salem Al Tamemi; Shoaib Al Zadjali; Saif Al Hosni; Melanie Tauro; Jamal Al Qassabi; Ibtisam Elnour; Rupert Handgretinger; David Dennison
Journal:  Transplant Cell Ther       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.